Growth in Cannabis Sales Remains Weak in September

New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s monthly cannabis sales data for 11 states.

Cannabis sales decreased 2.2% in September compared to August according to cannabis data analytics firm BDSA. Looking at a per-day basis, sales increased 1% month-over-month. In this review, we will look at the markets one-by-one, beginning with the eastern markets and then concluding with the western markets. In total, sales across the 11 markets totaled $1.64 billion during the month.

Eastern Markets

BDSA provides coverage for Florida, Illinois, Maryland, Massachusetts, Michigan and Pennsylvania. In September, year-over-year growth ranged from -13.1% in Maryland to 24.9% in Florida. Note that Florida, Maryland and Pennsylvania are medical-only markets.


In September, sales increased 2.1% sequentially to $200 million, up 24.9% from a year ago. This was down from 29.5% growth in August. Flower sales grew 33%, pre-rolls increased 38%, ingestibles gained 5% and concentrates expanded 27% year-over-year.


We previously published data released by the state showing that sales grew 0.2% from August and increased 3.1% from September 2021. BDSA estimated sales of $158.7 million, up 0.2% sequentially and 3.9% from a year ago. Compared to last year, flower sales were flat, pre-rolls jumped 29%, ingestibles fell 2% and concentrates increased 8%.


Sales decreased 4.2% from August to $38.3 million, down 13.1% from a year ago. Flower sales decreased 12%, pre-rolls declined 16% and concentrates fell 20%, while ingestibles were up 2% year-over-year.


Sales slipped 3% sequentially and increased 3.2% compared to a year ago to $148.8 million. Flower sales grew 2% and ingestibles gained 1%, pre-rolls increased 17% and concentrates declined 3% compared to last year.


We had previously written about data released by the state indicating that Michigan cannabis sales grew 2% sequentially and 31.4% year-over-year. BDSA estimated sales of $212 million, up 2% sequentially and 29.3% from a year ago. Flower sales increased 37%, while concentrates grew 22%. Pre-rolls jumped 57% and ingestibles gained 5% compared to prior year.


Sales declined 0.5% in September to $92.7 million, down 9.1% compared to a year ago. Flower sales decreased 5% year-over-year, concentrates fell 13%, while ingestibles were down 4%.

Western Markets

BDSA provides coverage for Arizona, California, Colorado, Nevada and Oregon. In September, year-over-year growth ranged from -24.7% in Nevada to -1.7% in California compared to a year ago.


Combined sales of $105.7 million decreased 2.5% from August, down 2.9% compared to September 2021. Medical sales of $39 million were down 8% sequentially and down 30% from a year ago. Adult-use sales of $66.7 million gained 1% from August and 26% year-over-year. Flower sales were down 14% from a year ago, while pre-rolls grew 49%. Concentrates fell 5% and ingestibles gained 8%.


California sales fell 5.5% sequentially to $395.3 million and decreased 1.7% compared to a year ago. Flower sales were down 11%, while pre-rolls grew 12%. Ingestibles gained 7% and concentrates were flat year-over-year.


Sales declined 3.9% in September compared to August, dropping 20.2% from a year ago to $144.5 million. Flower sales were down 23%, pre-rolls declined 14%, while concentrates fell 18%. Ingestibles declined 22% year-over-year.


Sales decreased 9.7% sequentially, falling 24.7% from a year ago to $58.2 million. Flower sales dropped 33% from a year ago. Concentrates fell 16%, while ingestibles decreased 22% and pre-rolls declined 15%.


Sales in September fell 1.4% from August to $81 million, down 15% from a year ago. Flower sales decreased 21% year-over-year. Ingestibles were down 10%, while pre-rolls and concentrates declined 10%.

For readers interested in a deeper look at cannabis markets across these eleven states and more, including segmentation by additional product categories, brand and item detail, longer history, and segmentation by product attributes, learn how BDSA Solutions can provide you with access to actionable data and analysis.

Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter